Life Sciences

Pharmaceutical and biotech companies face high costs, lagging profitability, and rigorous regulatory oversight. Business models continue to focus on the next “blockbuster” product, which increases cost pressures of extensive R&D processes, clinical trials, and attracting and retaining skilled workforces. At the same time, companies can experience dramatically shrinking margins for existing products, with generic competitors jumping on patent expirations and governments pushing for reduced prices. The growing use of joint ventures and strategic partnerships to share costs and risk create new sets of challenges such as full revenue recovery from complex agreements, and more complicated development, consumer, and financial reporting compliance.

REAL EXPERTISE

ABeam consultants specializing in business and technology solutions for pharmaceutical and biotech companies bring direct experience from working within the industry. Our experts know where and how to find cost efficiencies in complex R&D processes; evaluate potential partnerships and acquisitions for more productive product pipelines; and standardize various operational, marketing and sales processes for consistently higher global performance.

Our experience includes a wide range of highly successful ERP implementations for pharmaceutical and biotech companies, integration of global IT infrastructure, internal controls for SOX and J-SOX compliance, and validation of existing systems and processes. Join companies like Biogen Idec, Bristol-Meyers Squibb, Johnson & Johnson, Merck Serono and Schering-Plough that continue to increase their operational and competitive advantages with ABeam.